Project Grant HT94252410066
Award Date
1/15/24
Completion Date
1/14/26
Dollars Obligated
$311K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
University City, MO 63130, USA
Similar Awards
The federal Project Grant award, valued at $250,000.00, was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to The Washington University's Office of Sponsored Research Services Division. The award will fund a study on the "SUBCLINICAL PATHOPHYSIOLOGY OF MOTOR PROCESSING IN PEOPLE WITH MULTIPLE SCLEROSIS" over a 2-year period from September 30, 2024 to September 29, 2026. As a prominent private research university, The...
This $437,544 Project Grant award was made on September 30, 2023 by the Defense Health Agency under the CFDA 12.420 Military Medical Research and Development program. The grant supports research at The Washington University in St. Louis, Missouri to study the phosphorylation tau profile of veterans with traumatic brain injury (TBI). The 3-year research project aims to improve understanding of neurological conditions affecting military service members and veterans. As a prominent private research...
This federal Project Grant award of $155,500.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports research by The Washington University in University City, Missouri. The award, effective from September 30, 2025 to September 29, 2027, will investigate the "Pathophysiologic Effects of Obesogenic Diet in Neurofibromatosis Type 1 and Impact on Tumor Formation." This research aims to transform healthcare for military service members,...
The federal Project Grant award of $500,000.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports research at Washington University to accelerate the diagnosis of inflammatory arthritis. The project aims to harness single-cell T cell-receptor sequencing to develop innovative diagnostic approaches. The research is being conducted at Washington University's Office of Sponsored Research Services Division over a 2-year performance period from...
The Washington University in St. Louis School of Medicine was awarded a $933,911 project grant from the Department of the Army Medical Command on September 30, 2022. The grant is part of the Military Medical Research and Development program (CFDA 12.420) and will support basic, applied, and advanced biomedical research efforts through September 29, 2025. Specifically, the grant funding will enable research to transform healthcare for service members and the general public through innovative...
The Washington University Office of Sponsored Research Services Division received a $226,471.00 Project Grant from the Defense Health Agency under the Department of Defense's CFDA 12.420 Military Medical Research and Development program. The grant, awarded on Sep 30, 2023, will fund a study on the "PHOSPHORYLATION TAU PROFILE OF VETERANS WITH TBI" through Sep 29, 2026. As a leading research institution with expertise in biomedical research, the university will leverage its capabilities...
This Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) provides $1,399,500.00 to The Washington University's Office of Sponsored Research Services Division to research and develop an engineered interleukin-2/receptor complex for the treatment of chronic migraine and post-traumatic headache. The award period runs from September 1, 2023 through August 31, 2027. The Washington University has extensive experience...
The Department of Defense's Defense Health Agency awarded a $1,127,375 Project Grant to The Washington University Office of Sponsored Research Services Division under the Military Medical Research and Development program (CFDA 12.420). The grant, which runs from Sep 30, 2023 to Sep 29, 2027, will fund research on "REPLICATION DRIVEN VULNERABILITIES IN CYCLIN E OVEREXPRESSING OVARIAN CANCERS". As a prominent research institution with expertise in biomedical sciences, The Washington...
This Project Grant award, valued at $135,000.00, was provided by the U.S. Department of the Army Materiel Command Research Development and Engineering Command under the Basic Scientific Research program (CFDA 12.431). The grant will fund fundamental research on "HIERARCHICAL ADVERSARIAL REINFORCEMENT LEARNING FOR AUTONOMOUS CYBER DEFENSE" at The Washington University in University City, Missouri. The research, conducted from January 2025 through January 2028, aims to expand...
The Washington University will receive $1,260,000 from the Department of the Army Medical Command under the Military Medical Research and Development federal grant program (CFDA 12.420) to conduct research on mutagenic deaminase activity in cancer from September 2021 through September 2025. Through this four-year project grant award, The Washington University researchers in University City, Missouri will investigate mutagenic deaminase activity and its relationship to cancer development and...